Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-19T09:51:51.611Z Has data issue: false hasContentIssue false

A Case of Resolution of an Acute Psychotic Episode After High Fever

Published online by Cambridge University Press:  07 November 2014

Abstract

Fever (pyretotherapy) was used for psychosis during the turn of the 19th century, but pyretotherapy (ie, the treatment of a disorder by inducing fever) fell out of use after the introduction of convulsive methods. Here, we report on a case of schizoaffective disorder and review classical and recent literature on fever and psychosis. The patient developed auditory hallucinations, persecutory delusional ideas, and was terrified soon upon his arrival in a foreign country. After being treated for 12 days with olanzapine and haloperidol, he developed a fever due to urinary infection; his creatine phosphokinase levels were high, prompting the suspension of antipsychotics. Psychotic symptom resolution followed immediately fever abatement. Antipsychotics were reintroduced at lower dosages. He was discharged asymptomatic with a prescription of olanzapine 15 mg/day and haloperidol 3 mg/day. The time course of symptom resolution in this patient suggests that fever had a beneficial role in this case. The associations between body temperature changes and psychotic symptoms need to be further studied.

Type
Case Report
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Wagner-Jauregg, J. Über die Einwirkung fieberhafter Erkrankungen auf Psychosen. Jahbuch für Psychiatrie und Neurologie. 1887;7:94131.Google Scholar
2.Wagner-Jauregg, J. Lebenserinnerungen. Schonbauer, L, Jantsch, M, eds. Vienna, Austria: Springer Verlag; 1950.Google Scholar
3.Whitrow, M. Wagner-Jauregg and fever therapy. Med Hist. 1990;34:294310.CrossRefGoogle ScholarPubMed
4.Day, R, Nielsen, JA, Korten, A, et al.Stressful life events preceding the acute onset of schizophrenia: a cross-national study from the World Health Organization. Cult Med Psychiatry. 1987;11:123205.CrossRefGoogle ScholarPubMed
5.Srikanth, S, Ravi, V, Poornima, KS, Shetty, KT, Gangadhar, BN, Janakiramaiah, N. Viral antibodies in recent onset, nonorganic psychoses: correspondence with symptomatic severity. Biol Psychiatry. 1994;36:517521.CrossRefGoogle ScholarPubMed
6.Collins, PY, Wig, NN, Day, R, et al.Psychosocial and biological aspects of acute brief psychoses in three developing country sites. Psychiatr Q. 1996;67:177193.CrossRefGoogle ScholarPubMed
7.Malhotra, S, Varma, VK, Misra, AK, Das, S, Wig, NN, Santosh, PJ. Onset of acute psychotic states in India: a study of sociodemographic, seasonal and biological factors. Acta Psychiatr Scand. 1998;97:125131.CrossRefGoogle ScholarPubMed
8.Collins, PY, Varma, VK, Wig, NN, Mojtabai, R, Day, R, Susser, E. Fever and acute brief psychosis in urban and rural settings in north India. Br J Psychiatry. 1999;174:520524.CrossRefGoogle Scholar
9.Farooq, S, Khawaja, MY. Fever and acute brief psychosis in developing countries. Br J Psychiatry. 1999;175:586.CrossRefGoogle ScholarPubMed
10.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Pscyhiatric Association; 1994.Google Scholar
11.Kapur, S, Arenovich, T, Agid, O, Zipursky, R, Lindborg, S, Jones, B. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005;162:939946.CrossRefGoogle ScholarPubMed
12.Kapur, S, Agid, O, Mizrahi, R, Li, M. How antipsychotics work-from receptors to reality. NeuroRx. 2006;3:1021.CrossRefGoogle ScholarPubMed
13.Agid, O, Seeman, P, Kapur, S. The “delayed onset” of antipsychotic action-an idea whose time has come and gone. J Psychiatry Neurosci. 2006;31:93100.Google Scholar
14.Emsley, R, Rabinowitz, J, Medori, R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry. 2006;163:743745.CrossRefGoogle ScholarPubMed
15.Sternbach, H, State, R. Antibiotics: neuropsychiatric effects and psychotropic interactions. Harv Rev Psychiatry. 1997;5:214226.CrossRefGoogle ScholarPubMed
16.Marek, J. On the non specific antiinflammatory effects of other than antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs. Int J Tissue React. 1985;7:475504.Google ScholarPubMed
17.Stevens, JR, Denney, D, Szot, P. Kindling with clozapine: behavioral and molecular consequences. Epilepsy Res. 1996;26:295304.CrossRefGoogle ScholarPubMed
18.Overholser, W. Mental Hygiene. Proc Am Philosoph Soc. 1946;90:259264.Google ScholarPubMed
19.Keck, PE Jr, Caroff, SN, McElroy, SL. Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy? J Neuropsychiatry Clin Neurosci. 1995;7:135144.Google ScholarPubMed
20.Ford, DM, Klugman, KP. Contrasting roles of 5-hydroxytryptamine and noradrenaline in fever in rats. J Physiol. 1980;304:5157.CrossRefGoogle ScholarPubMed
21.Bymaster, FP, Calligaro, DO, Falcone, JF, et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 1996;14:8796.CrossRefGoogle ScholarPubMed
22.Richelson, E, Souder, T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000;68:2939.CrossRefGoogle ScholarPubMed